News | March 20, 2024
AstraZeneca buys biopharmaceutical company Fusion
To accelerate the development of next-generation radioconjugates to treat cancer
To accelerate the development of next-generation radioconjugates to treat cancer
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3) targeting T-cell engager
Women emerge as the cornerstone of this monumental undertaking
The inspection was concluded with few procedural observations
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Dr Sheth's will commission a Healthmobile on Wheels initiative to ensure that healthcare doesn't remain confined to urban centers
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
